Golden Helix said last week that Millennium Science will distribute its genetic analysis software in Australia and New Zealand.
Under the agreement, Millennium, based in Surrey Hill, Australia, will provide sales and support for the company's SNP and Variation Suite, which is aimed at researchers involved in genome-wide association, copy number analysis, and next-generation sequencing research.
Millennium Managing Director and CEO Bren Collinson said in a statement that the Golden Helix software will "accelerate our customers search for the genetic causes of disease, the development of diagnostics, and pharmacogenetic research."
Financial details of the pact were not discussed.
Golden Helix, based in Bozeman, Mont., last year launched the seventh version of its SNP & Variation Suite for SNP and copy number analysis. The new version was designed to overcome data-capacity constraints, limited visualization capabilities, and data-workflow challenges associated with high-density SNP-genotyping arrays and second-generation sequencers.
Among the new features included in SVS 7 were interactive visualization and an integrated genome browser; real-time data editing and enrichment; advanced predictive modeling; quality assurance and stratification correction; and enhanced genome-wide association analyses including the ability to use genetic covariates in regression (see BAN 2/10/2009).